EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   7.2.2.10 | 6-phosphofructokinase deficiency |
16584991 |
The contribution of Ca2+-calmodulin activation of human erythrocyte AMP deaminase (isoform E) to the erythrocyte metabolic dysregulation of familial phosphofructokinase deficiency. |
causal interaction
ongoing research
unassigned |
3
1
0 |
| 7.2.2.10 | 6-phosphofructokinase deficiency |
16670071 |
The contribution of Ca+ calmodulin activation of human erythrocyte AMP deaminase (isoform E) to the erythrocyte metabolic dysregulation of familial phosphofructokinase deficiency. |
causal interaction
ongoing research
unassigned |
3
1
0 |
| 7.2.2.10 | Acantholysis |
22045735 |
Protein aggregation of SERCA2 mutants associated with Darier disease elicits ER stress and apoptosis in keratinocytes. |
causal interaction
unassigned |
2
0 |
| 7.2.2.10 | Acantholysis |
29761773 |
[Dyskeratosis follicularis]. |
unassigned |
0 |
| 7.2.2.10 | Acantholysis |
30692201 |
Synergy among non-desmoglein antibodies contributes to the immunopathology of desmoglein antibody-negative pemphigus vulgaris. |
ongoing research
unassigned |
3
0 |
| 7.2.2.10 | Acantholysis |
31958740 |
Mechanisms of synergy of autoantibodies to M3 muscarinic acetylcholine receptor and secretory pathway Ca2+/Mn2+-ATPase isoform 1 in patients with non-desmoglein pemphigus vulgaris. |
ongoing research
unassigned |
2
0 |
| 7.2.2.10 | Acantholysis |
34272745 |
Weak immunohistochemical expression of galectin-3 near blisters in Hailey-Hailey disease. |
causal interaction
unassigned |
3
0 |
| 7.2.2.10 | Acidosis |
239798 |
Glycoside inotropy in the absence of an increase in potassium efflux in the rabbit heart. |
therapeutic application
unassigned |
1
0 |
| 7.2.2.10 | Acidosis |
8107693 |
Effect of pH on stability of sarcoplasmic reticulum calcium pump in rabbit heart. |
causal interaction
therapeutic application
unassigned |
3
1
0 |
| 7.2.2.10 | Acidosis |
8238559 |
Coronary artery acidosis: pH and calcium pump stability. |
causal interaction
therapeutic application
unassigned |
2
1
0 |
